The aim of this study was to investigate the effects of sildenafil on ocular hemodynamics by color Doppler ultrasonography (CDU). In all, 38 patients with erectile dysfunction diagnosed by International Index of Erectile Function (IIEF) and Sexual Health Inventory of Men (SHIM) scores were included into the study. After taking 100 mg of oral sildenafil citrate, all patients underwent CDU examination of central retinal artery at 60 and 75 min and CDU examination of cavernosal artery at 20, 60 and 75 min. All of the side effects during and after the test were also recorded. The mean cavernous artery peak systolic flow velocity increased significantly after sildenafil. However, no significant change was determined in central retinal artery flow parameters including peak systolic flow velocity, end-diastolic flow velocity, resistive index, pulsatility index, volume and diameter. Five patients experienced ocular side effects. No significant change was observed in retinal artery CDU measurements of patients having ocular side effects. Sildenafil has no effect on ocular hemodynamics on the basis of CDU. Ocular side effects may be the result of other changes in retinal photoreceptors rather than the ocular circulation.
Introduction
Erectile dysfunction is defined as the persistent inability to achieve or maintain penile erection sufficient for sexual intercourse. In the past, patients have under-reported this problem because of embarrassment and the belief that little could be done to alleviate it. The availability and marketing of new therapies for erectile dysfunction have greatly increased public awareness of this problem. With the introduction of effective pharmacologic therapies for erectile dysfunction, more men are seeking treatment. 1 Sildenafil citrate is a safe and effective treatment of erectile dysfunction. Sildenafil inhibits phosphodiesterase (PDE)-5 in the corpus cavernosum to facilitate penile erection. 2 The drug also has a mild inhibitory effect on PDE-6, which controls the level of cyclic guanosine monophosphate (cGMP) in the retina, and it may cause a perception of bluish haze or increased light sensitivity in some patients. 3 Although the drug is marketed solely as therapy for erectile dysfunction, its ability to intensify and prolong the erectile response has led to off-label and illicit use as a sexual potency drug, and therefore there is a high potential for abuse in terms of selfdosage at inappropriate levels of frequency. 4 Patients who require sildenafil for erectile dysfunction are usually elderly patients with vascular diseases and may suffer from vascular accidents within the eye. More critically, the drug also can cause transient visual symptoms because of its direct effect on retinal chemistry and certain questions about its long-term ocular safety remain unresolved. Many patients using the drug may have underlying retinal disease susceptible to side effects or toxicity and subtle changes or unusual risks for subpopulations can be missed for long periods of time. Finally, although the Food and Drug Administration have deemed the drug safe, the long-term data on ocular safety are not as complete as they might be. 5, 6 The aim of this study was to investigate the effects of sildenafil on ocular perfusion using color Doppler ultrasonography (CDU).
Materials and methods
In all, 38 patients between 23.6 to 71.9 y of age (mean age 55.8710.6 y) were included in the study after the approval of the local Ethics Committee of our Faculty of Medicine. Detailed information about the study and possible side effects of sildenafil was given to each patient and all patients were provided to give written consent to participate. All participants had at least 6 months of erectile dysfunction that had been proved with both Sexual Health Inventory of Men (SHIM) and International Index of Erectile Function (IIEF) scores. All patients underwent complete diagnostic evaluation including detailed medical and sexual history, physical and neurological examination and biochemical testings (The routine biochemical profile including fasting glucose, sodium, potassium, chlorine, calcium, BUN, serum creatinine, ALT, AST, ALP, LDH, CK, bilirubin, total protein and albumin; the lipid profile including serum cholesterol, triglycerides, HDL and LDL.)
CDU examinations of the cavernous and central retinal arteries of the patients were performed by the same investigator using a linear 7-12 MHz broadband transducer of an ATL 1500 scanner (Bothell, Washington, USA). Before CDU examination, systemic arterial blood pressures of the patients were recorded. The patients were taken to the examination room and a brief cervical CDU examination was carried out to exclude carotid occlusion or significant stenosis. Then the room was provided to be devoid of the any external audiovisual stimuli and light level arranged constantly. At 5 min after the entrance of the patients to the room in which time the eye accommodation to room light was established, CDU examination of central retinal artery was performed and the results constituted the 'minute 0' values. After oral ingestion of 100 mg sildenafil, all patients were left alone in the examination room to watch an erotic video to provide audio-visual stimulation. Central retinal artery was examined after sildenafil administration at 60 and 75 min. Cavernosal artery was examined at 20, 60 and 75 min after sildenafil administration. Cavernosal artery was examined first and then the central retinal artery almost in the same minute, after the transducer was cleaned. Examinations were performed as rapidly as possible to avoid the loss of concentration of the patients for sexual arousal and then the patients left alone to continue watching the video display between the evaluations. For the same reason, only the right eye and the right cavernosal artery were evaluated. Arterial blood pressures of the patients were recorded at 75 min of sildenafil administration, after completion of CDU examinations.
The examination of cavernosal artery was performed while the patient was in supine position, penis was slightly stretched to the abdomen and the transducer was placed on the ventral penile surface. Cavernous artery was found by color encoding at the penoscrotal junction and spectral waveforms of the artery were recorded in proximal parts with appropriate angle correction, maintaining the Doppler angle between 30 and 601. Peak systolic flow velocity (V max ) and end-diastolic flow velocity (V min ) of the cavernous artery were calculated from the recorded waveforms.
The examination of the central retinal artery was performed on the right eye in all patients. The patient was in supine position and the eyelids were closed, the transducer was placed horizontally on the eye. Using the posterior compartment as an acoustic window, the optic nerve in the posterior aspect of the globe was sonographically detected. Then the central retinal artery was found by color Doppler encoding at the point of its entry to the globe, near the optic nerve. Doppler spectral waveforms of the central retinal artery were obtained maintaining the Doppler angle between 45 and 601. The Doppler parameters of the recorded waveforms were calculated including V max , V min , resistive index (RI), pulsatility index (PI), diameter and volume of the central retinal artery.
Patients were informed about the drug, and any side effects that patients reported during the examination or their own use at home at least of four to six doses were recorded. The results of the study are obtained as the mean plus or minus standard deviations. Statistical analysis was performed using the analysis of variance, the Wilcoxon's rank-sum test and Pearson's correlation analysis as appropriate. A computer software (SPSS 11.0 for Windows) was used for all statistical analysis with Po0.05 was considered statistically significant.
Results
The mean SHIM scores of the patients were 12.3974.0, and according to erectile function scores from the IIEF (questions 1-5 and 15) six patients (15. 8%) suffered from severe ED and 13 (34.2%) moderate ED and 19 (50%) were mildly affected. There were hypertension in 13 (34.2%) patients, diabetes mellitus in 14 (36.8%) patients, coronary artery disease in eight (21%) patients and 20 patients (52.6%) were smokers. The biochemical results of blood testing were within normal range.
The Five (13.1%) patients described ocular side effects and 15 (39.4%) had complaints of nonocular side effects. The reported side effects are shown in Table 2 . Ocular side effects that patients described were 'unformed flashes of light' in two patients, 'blurred vision' in one patient, 'increased light sensitivity to light' in one patient and 'sensation of flying objects' in one patient. The mean age of the patients with ocular side effects was 62.5475.95 y, who were older than the patients with nonocular side effects and with no side effects (54.79710.82 y of age) (P ¼ 0.042).
The mean arterial blood pressures in patients with ocular side effects were 13479.62/8775.70 and 13077.90/8276.71 mmHg at the 0 and 75 min of sildenafil administration (P ¼ 0.102/0.059) and for the patients with nonocular side effects 13577.79/ 86.6774.44 and 131.777.69/8276.02 mmHg, respectively (P ¼ 0.023/0.005). There was a statistically significant decrease in both systolic and diastolic arterial blood pressures of patients with nonocular side effects after 75 min of sildenafil administration. The decrease in systemic arterial blood pressures of patients within the group of ocular side effects was not significant.
Discussion
Visual symptoms after sildenafil are known to be dose dependent and roughly 3, 11 and 50% with dose of 50, 100 and 200 mg, respectively. 7 The drug has relatively few side effects (headache, flushing, nasal congestion, etc), which are considered to occur because of its systemic vasodilatatory effects. 8 There is a small risk that these vascular effects might be reflected in the eye with an increase in choroidal blood flow or choroidal congestion. The human choroid, which supports the metabolic function of the outer retina is an erectile tissue, and is analogous to the corpus cavernosum in many aspects. 9 On the other hand, sildenafil has roughly 10% effectiveness on PDE6 localized at photoreceptors of the retina, which is the key enzyme modulating the process of transduction, by which light energy is converted to a neural signal. While cGMP concentration is high during darkness, it is lowered during light. With the blockage of PDE6 continuously, persistence of cGMP may accumulate and destruct retinal function. 4 Prerelease studies have examined the effects of sildenafil on visual measures. [10] [11] [12] Gabrieli et al 10 have found that sildenafil administration resulted in a higher rod response to light stimuli and in a higher rod sensitivity due to weak PDE6 inhibition induced by sildenafil. Vobig et al 11 have found a significant reduction in the amplitude of maximal scotopic a-wave and b-wave in five volunteers, 1 h after taking 100 mg sildenafil. The ERG findings returned to normal 6 h after sildenafil administration and no changes in b-wave latency were reported. Kretschman et al 12 observed an increase in scotopic b-wave latency without the loss of amplitude in six patients taking 100 mg sildenafil.
In our study, we found out that sildenafil caused a significant increase in cavernosal arterial blood flow as described previously. 13 The increase in cavernosal arterial blood flow was used as an objective parameter of the response to sildenafil before making some proposal about the retinal arterial changes. In contrary to cavernous artery, no change in ocular perfusion was detected in our study group on the basis CDU findings, even in the patients with ocular side effects. Our study design did not include the correlation of the CDU parameters of the central retinal artery with the visual parameters. The parameters as visual acuity and color vision indices might be suggested to consider for comparison 14-18 Sponsel et al 14 investigated increase in pulsatile ocular blood flow about one-third of baseline values 2 h after 50 mg sildenafil administration in 12 healthy subjects and profound intrinsic change in choroidal vasculature using the Heidelberg retinal flowmetry technique. In a doubleblind crossover trial, Grunwald et al 15 have concluded that sildenafil causes no significant change in optic nerve rim or foveolar choroidal blood flow 1 and 5 h after 100 mg sildenafil administration. Study of Sponsel and co-workers, using conventional Heidelberg retinal flowmetry technique that estimates pulsatile blood flow out of the intraocular pressure produced by cardiac cycle is criticized, in that any pharmacologic medication could increase pulsatile component of blood flow, while decreasing nonpulsatile component results in no change in total blood flow. Hayreh 16 claimed that laser Doppler flowmetry is predominantly sensitive to changes in the superficial layers of the optic nerve head on the basis of the study performed by Petrig et al. 17 The technique we used in our study, CDU, has some superior aspects when compared to the other techniques measuring ocular blood flow, in that it has the capability to show hemodynamics in vessels that are optically not visible, there is no need to use of mydriatic agents and light that may affect the ocular blood flow and have more comparable standardized results.
Dundar et al 18 using CDU technique have shown a significant increase in mean V max and V min of the ophthalmic arteries in 14 healthy volunteers whose mean age was 27.01 y. At the same study no significant change in ocular blood flow of central retinal and short ciliary arteries were found. Although ophthalmic artery is the main vascular supply of the retina, its branches, central retinal and posterior ciliary arteries are more important because they are the sole arterial supplies of the retina. Central retinal artery, different from ophthalmic artery, is an end artery with equal blood flow in arterioles and venules at the periphery. Apart from this, central retinal artery has an autoregulation system, which modifies ocular circulation by retinal cellular metabolites. 19 Therefore, the results of central retinal arterial measurements are more predictable about ocular perfusion than ophthalmic artery, which should be considered as a part of systemic circulation.
In the standing position, nearly 10 mmHg decrease in ophthalmic arterial pressure occurs resulting in an increase in ocular circulation. In supine position, pulsatile retinal blood flow decreases by 27.5%, which is autoregulated by the retinal circulation. Entry into a dark room, on the other hand, causes 40-55% increase in retinal blood flow circulation and adaptive levels are established usually after 5 min. 20, 21 While measuring ocular perfusion, utmost importance should be given to postural and light changes like in our study design.
Our study population represents a realistic group that is composed of patients requiring sildenafil for their erectile dysfunctions who are elderly and are more prone to retinal and macular changes. Chronic diseases such as diabetes mellitus, hypertension, coronary artery disease and hyperlipidemia have been found to have no influence on ocular circulation like the five patients of our study group describing ocular side effects after sildenafil administration. Patients with ocular side effects were much older than other patients with nonocular side effects and patients with no side effects. It is known that retinal thickness significantly decreases with diminished retinal capillaries and decreased rodcone photoreceptor density with age, and retina becomes more prone to metabolic changes. [22] [23] [24] Another result of our study was a marked decrease in both systolic and diastolic systemic arterial blood pressures in patients with nonocular side effects as compared to patients with ocular side effects and patients with no side effects. This may support that ocular side effects are the result of interaction of sildenafil molecules with retinal photoreceptors and nothing to do with systemic vasodilatatory effects.
Conclusions
CDU is a noninvasive method for interpretation of ocular circulation. Sildenafil has no effect on central retinal arterial circulation on the basis of CDU. Ocular side effects seem to be the result of sildenafil that inhibits PDE6 molecules at the retinal photoreceptor level. Visual symptoms are more likely seen in elderly patients. To our knowledge retinal toxic effects are not clearly understood, therefore older and patients with retinal diseases should be fully informed about the potential risks.
